Trump Administration

31 Dec

Trump Admin Proposes Gender-Affirming Care Bans

DoryLatest News, , , , , ,
The Trump Administration released two proposed rules intentionally designed to make gender affirming care for young people impossible to access. In one rule, federal Medicaid reimbursement is banned for medical care provided to transgender patients under 18 and prohibits reimbursements through CHIP (Children’s Health Insurance Program) for transgender patients under 19. In the other rule, the administration is planning to block all Medicaid and Medicare funding for services at hospitals that provide gender affirming to young people.
Read More
21 Dec

How much of Project 2025 has actually been accomplished this year?

CoreyLatest News, , , , , ,
In the months leading up to his election, President Donald Trump insisted that he had nothing to do with the far-right vision for his second administration known as Project 2025, a Christian-nationalist blueprint to remake the federal government. As the year draws to a close, a crowd-sourced effort, as well as trackers from advocacy organizations and labor unions, show that his administration has implemented roughly half of the goals laid out in the document’s 920 pages.
Read More
19 Dec

Moments of hope in a year of turmoil

ChaseLatest News, , , , ,
Cuts to humanitarian aid funding by the US government and other international donors disrupted care and key programs safeguarding the health and wellbeing of vulnerable people, while conflicts, natural disasters, and climate-related events continued to put communities at risk. But as Doctors Without Borders/Médecins Sans Frontières (MSF) teams responded to many of these crises, they also bore witness to moments of hope shining a light on the prevailing human spirit in moments of adversity.
Read More
13 Dec

CDC Delays Annual Abortion Report Amid Internal Turmoil

PhoenixLatest News, , , , ,
The U.S. Centers for Disease Control and Prevention's yearly abortion report is delayed due to staffing and internal issues Abortions increased about 4% in early 2025, new data shows, with 27% now provided through telehealth Many were provided under shield laws, which allow clinicians in states where abortion is legal to prescribe medication across state lines For decades, the U.S. Centers for Disease Control and Prevention (CDC) has released a yearly report tracking abortion trends across the country. 
Read More
28 Nov

Democratic U.S. Senators Raise Alarm Over Trump Administration Efforts to Restrict Mifepristone

RileyLatest News, , , , ,
U.S. Senators Mark R. Warner and Tim Kaine, a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, (both D-VA) joined Senator Patty Murray (D-WA) and all of their Democratic Senate colleagues in sending a letter to U.S. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. and U.S. Food and Drug Administration (FDA) Commissioner Marty Makary expressing alarm over the Trump Administration's plans to reexamine the safety and effectiveness of mifepristone. Since 2000, mifepristone has been approved by the FDA as a safe and effective medication for abortion care and miscarriage management. The Administration’s basis…
Read More
26 Nov

Understanding the Trump Administration’s Negotiated Drug Prices for Medicare

RandyLatest News, , , , , ,
The Centers for Medicare & Medicaid Services (CMS) has just announced the prices that the federal government negotiated for 15 high-cost drugs covered by Part D, Medicare’s prescription drug benefit program, including the popular diabetes and obesity drugs Ozempic and Wegovy. This brings to a close the second round of Medicare’s Drug Price Negotiation Program, which was created by the Inflation Reduction Act of 2022 under the Biden administration. These negotiated prices will take effect in Medicare in January 2027.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.